LTT BIO-PHARMA CO LTD has a total of 22 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2010. It filed its patents most often in Japan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VAMVAKIDES ALEXANDRE, SELAMINE LTD and ANJI PHARMA US LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Enzymes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Mizushima Toru | 13 |
#2 | Mizushima Tohru | 9 |
#3 | Takahashi Yuji | 4 |
#4 | Yamashita Yasunobu | 3 |
#5 | Yamakawa Naoki | 3 |
#6 | Liu Hongxing | 1 |
#7 | Tanaka Kenichiro | 1 |
Publication | Filing date | Title |
---|---|---|
JP2020050624A | Pharmaceutical composition for treating fibrosis | |
JP2017149663A | Irritable bowel syndrome therapeutic agent | |
JP2017052723A | Dry eye improver | |
JP2016132619A | Alzheimer's disease therapeutic agent | |
EP3087983A1 | Eye drops for treating dry eye | |
JP2012031076A | Cancer stem cell differentiation inducer |